JP2007505854A - 糖尿病の治療および予防用組成物 - Google Patents

糖尿病の治療および予防用組成物 Download PDF

Info

Publication number
JP2007505854A
JP2007505854A JP2006526578A JP2006526578A JP2007505854A JP 2007505854 A JP2007505854 A JP 2007505854A JP 2006526578 A JP2006526578 A JP 2006526578A JP 2006526578 A JP2006526578 A JP 2006526578A JP 2007505854 A JP2007505854 A JP 2007505854A
Authority
JP
Japan
Prior art keywords
pparγ
composition
treatment
ligand
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006526578A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007505854A5 (https=
Inventor
レドゥールストーフ，ダニエル
ティシェイラ，サンドラ・レナータ
ワン，イン
ヴェーバー，ペーター
ヴォルフラム，スヴェーン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2007505854A publication Critical patent/JP2007505854A/ja
Publication of JP2007505854A5 publication Critical patent/JP2007505854A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2006526578A 2003-09-23 2004-09-15 糖尿病の治療および予防用組成物 Pending JP2007505854A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03021447 2003-09-23
PCT/EP2004/010283 WO2005027661A1 (en) 2003-09-23 2004-09-15 Compositions for the treatment and prevention of diabetes mellitus

Publications (2)

Publication Number Publication Date
JP2007505854A true JP2007505854A (ja) 2007-03-15
JP2007505854A5 JP2007505854A5 (https=) 2011-06-23

Family

ID=34354421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526578A Pending JP2007505854A (ja) 2003-09-23 2004-09-15 糖尿病の治療および予防用組成物

Country Status (6)

Country Link
US (1) US7691420B2 (https=)
EP (1) EP1662906A1 (https=)
JP (1) JP2007505854A (https=)
KR (1) KR20060121887A (https=)
CN (1) CN100518733C (https=)
WO (1) WO2005027661A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013177334A (ja) * 2012-02-28 2013-09-09 Maruzen Pharmaceut Co Ltd Ｕｃｐ−３発現促進剤
JP2014065672A (ja) * 2012-09-25 2014-04-17 Nippon Menaade Keshohin Kk 幹細胞から褐色脂肪細胞への分化促進剤
JP2014527506A (ja) * 2011-06-02 2014-10-16 ユリエヴィッチ レシコフ，セルゲイ 糖尿病治療のための組み合わせ
JP2015155383A (ja) * 2014-02-19 2015-08-27 株式会社東洋新薬 受容体発現亢進剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1605336A (zh) 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
KR20080020617A (ko) * 2005-06-07 2008-03-05 디에스엠 아이피 어셋츠 비.브이. (-)-에피갈로카테킨 갈레이트의 신규 용도
US20090202659A1 (en) * 2005-06-10 2009-08-13 Gimble Jeffrey M Modulation of Peripheral Clocks in Adipose Tissue
EA200802090A1 (ru) * 2006-03-31 2010-04-30 ДСМ АйПи АССЕТС Б.В. Новое применение соединений и комбинаций соединений для улучшения внешнего вида
CN101516386B (zh) * 2006-07-14 2013-05-15 帝斯曼知识产权资产管理有限公司 包含玫瑰果和其它活性剂的用于治疗炎性病症的组合物
US20100215782A1 (en) * 2008-10-22 2010-08-26 Metaproteomics, Llc Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis
WO2011000593A1 (en) * 2009-06-30 2011-01-06 Unilever Plc Method for determining susceptibility of individuals to polyphenols
EP2332427A1 (en) * 2009-12-07 2011-06-15 Nestec S.A. low caloric fat replacers
WO2011162320A1 (ja) * 2010-06-23 2011-12-29 国立大学法人九州大学 Egcgまたはメチル化egcgとpde阻害剤との組み合わせ
CN107446882B (zh) * 2016-05-20 2021-06-22 东华大学 亚丁基苯酞的应用
WO2021263072A1 (en) * 2020-06-25 2021-12-30 Dana-Farber Cancer Institute, Inc. Methods of treating disease
CN119656183A (zh) * 2024-09-30 2025-03-21 唐宁医药科技(济南)有限公司 一种归知糖疽有效成分配方在治疗糖尿病引起的周围神经病变中的应用

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02243622A (ja) * 1989-03-16 1990-09-27 Nippon Oil & Fats Co Ltd 血中コレステロール低下用油脂組成物
JPH03228664A (ja) * 1990-02-02 1991-10-09 Meiji Seika Kaisha Ltd 脂質の消化吸収抑制機能を有する食品
JPH0517364A (ja) * 1991-07-08 1993-01-26 Mitsui Norin Kk シユクラーゼ活性阻害剤
JPH1118722A (ja) * 1997-07-03 1999-01-26 Lotte Co Ltd 記憶力および学習能力を増強させる効果を有する脳機能を活性化する飲食物
JPH11127826A (ja) * 1997-11-04 1999-05-18 Mitsubishi Kagaku Foods Kk 密封容器入り食品
WO2002069994A2 (en) * 2001-03-07 2002-09-12 Novo Nordisk A/S Combined use of derivatives of glp-1 analogs and ppar ligands
WO2002080936A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
JP2002326932A (ja) * 2001-03-02 2002-11-15 Kao Corp 体内脂肪燃焼促進剤
JP2003081825A (ja) * 2001-09-07 2003-03-19 Kao Corp カテキン含有飲料
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びｇｌｕｔ４トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
JP2003169641A (ja) * 2001-09-28 2003-06-17 Kao Corp 容器詰飲料

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
JPH01207233A (ja) 1988-02-12 1989-08-21 Tsumura & Co 抗動脈硬化症剤
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
JPH05292886A (ja) 1992-04-21 1993-11-09 Fuji Oil Co Ltd 被マイグレーション防止能を有する油脂及びそれを含有 した食品並びに油脂含有食品のマイグレーション防止法
JPH05292885A (ja) * 1992-04-22 1993-11-09 Asahi Denka Kogyo Kk チョコレート組成物
IN178310B (https=) 1993-06-25 1997-03-22 Mobius Consultancy Pty Ltd
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
CN1069036C (zh) * 1995-07-21 2001-08-01 崔景岳 灵芝仙饮
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
US6410061B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins as cancer specific proliferation inhibitors
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
CN1182127C (zh) 2000-06-28 2004-12-29 中国医学科学院药物研究所 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
US6455078B1 (en) * 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
US7968139B2 (en) * 2000-11-17 2011-06-28 Kao Corporation Packaged beverages
ITVR20010031A1 (it) 2001-03-12 2002-09-12 Hisanori Suzuki Uso di epigallocatechin-3-gallato o suoi derivati nella profilassi e nel trattamento delle malattie neurodegenerative.
DE10131057A1 (de) 2001-06-29 2003-01-23 Shandong Luya Pharmaceutical C Weiche, Angelikaöl enthaltende Gelkapsel und deren Herstellung
US6447814B1 (en) * 2001-08-28 2002-09-10 Yung Shin Pharma Ind. Co. Ltd. Chinese herbal composition for improving blood circulation and the method of preparing the same
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
JP3643081B2 (ja) * 2002-02-13 2005-04-27 株式会社京都栄養化学研究所 健康食品の製造方法
US20030165580A1 (en) * 2002-03-04 2003-09-04 Xinxian Zhao Safe pharmaceutical composition for treatment and prevention of gynecological disease
US20050256178A1 (en) * 2002-08-23 2005-11-17 Eggersdorfer Manfred L Novel nutraceutical compositions comprising boitin
KR100504408B1 (ko) 2002-10-29 2005-07-27 주식회사 코리아나화장품 생큐노라이드 ａ를 포함하는 피부 미백용 화장료 조성물
JP2006508096A (ja) 2002-11-07 2006-03-09 ディーエスエム アイピー アセッツ ビー．ブイ． 没食子酸エピガロカテキンを含む新規な栄養補助組成物

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02243622A (ja) * 1989-03-16 1990-09-27 Nippon Oil & Fats Co Ltd 血中コレステロール低下用油脂組成物
JPH03228664A (ja) * 1990-02-02 1991-10-09 Meiji Seika Kaisha Ltd 脂質の消化吸収抑制機能を有する食品
JPH0517364A (ja) * 1991-07-08 1993-01-26 Mitsui Norin Kk シユクラーゼ活性阻害剤
JPH1118722A (ja) * 1997-07-03 1999-01-26 Lotte Co Ltd 記憶力および学習能力を増強させる効果を有する脳機能を活性化する飲食物
JPH11127826A (ja) * 1997-11-04 1999-05-18 Mitsubishi Kagaku Foods Kk 密封容器入り食品
JP2002326932A (ja) * 2001-03-02 2002-11-15 Kao Corp 体内脂肪燃焼促進剤
WO2002069994A2 (en) * 2001-03-07 2002-09-12 Novo Nordisk A/S Combined use of derivatives of glp-1 analogs and ppar ligands
WO2002080936A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
JP2003081825A (ja) * 2001-09-07 2003-03-19 Kao Corp カテキン含有飲料
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びｇｌｕｔ４トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
JP2003169641A (ja) * 2001-09-28 2003-06-17 Kao Corp 容器詰飲料

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014527506A (ja) * 2011-06-02 2014-10-16 ユリエヴィッチ レシコフ，セルゲイ 糖尿病治療のための組み合わせ
JP2013177334A (ja) * 2012-02-28 2013-09-09 Maruzen Pharmaceut Co Ltd Ｕｃｐ−３発現促進剤
JP2014065672A (ja) * 2012-09-25 2014-04-17 Nippon Menaade Keshohin Kk 幹細胞から褐色脂肪細胞への分化促進剤
JP2015155383A (ja) * 2014-02-19 2015-08-27 株式会社東洋新薬 受容体発現亢進剤

Also Published As

Publication number Publication date
US7691420B2 (en) 2010-04-06
US20070042057A1 (en) 2007-02-22
EP1662906A1 (en) 2006-06-07
WO2005027661A1 (en) 2005-03-31
CN1856303A (zh) 2006-11-01
KR20060121887A (ko) 2006-11-29
CN100518733C (zh) 2009-07-29

Similar Documents

Publication Publication Date Title
US7691420B2 (en) Compositions for the treatment and prevention of diabetes mellitus
KR100591045B1 (ko) 당뇨병용 조성물
CA2645833C (en) Compositions containing riboflavin and sesamin-class compounds
JP2006520335A (ja) 脂肪酸とアミノ酸を含有する組成物
US9889173B2 (en) Composition for improving macular pigment density and preventing or treating age-related macular degeneration
JP6360972B2 (ja) 白扁豆抽出物を有効成分として含む非アルコール性脂肪肝疾患の予防または改善のための組成物
WO2001087291A1 (fr) Compositions permettant de regulariser le rythme circadien
CN103998051A (zh) 桑属浆果及其避免血糖峰值的用途
JP2007238441A (ja) アスタキサンチンを有効成分とする体脂肪減少用組成物
KR100877600B1 (ko) 메타독신 및 마늘유를 유효성분으로 함유하는 알코올성지방간 및 지방간성 간염의 예방 및 치료용 약학 조성물
KR20220152237A (ko) 장쇄 지방산을 포함하는 안구 건강용 조성물 및 방법
JP7423731B2 (ja) 疲労感、意欲低下または眠気の改善剤
JP2016199491A (ja) 気分状態改善剤
KR101811210B1 (ko) 마가목 열매 추출물을 유효성분으로 하는 당뇨 질환 치료, 개선 또는 예방용 조성물
KR20060021383A (ko) 운동 생리 기능 향상제
JPWO2005095414A1 (ja) アディポネクチン上昇剤
JP2008143811A (ja) 脂質代謝促進組成物
US20100028457A1 (en) Agent for prevention or treatment of blood glucose level elevation
KR20250128382A (ko) 코엔자임 q10을 포함하는 건강을 위한 조성물 및 방법
KR101719015B1 (ko) 프루네틴을 유효성분으로 함유하는 비만 또는 대사성 질환의 예방 또는 치료용 약학적 조성물
JP2006022064A (ja) 動脈硬化の予防及び／又は改善剤、機能性食品、又は化粧料
JP7833758B2 (ja) １型糖尿病の改善又は治療剤
JP2012201593A (ja) 糖尿病性脂肪肝の予防・改善・治療用組成物
KR101147913B1 (ko) 혈당 조절용 조성물
JP2020105090A (ja) 脂質吸着剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110131

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120207

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120717